Form 4: Merit Medical Systems COO Neil Peterson Executes Stock Options and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Neil Peterson, Chief Operating Officer of Merit Medical Systems, exercised stock options and sold 7,500 shares of common stock at an average price of $81.846 per share on June 10, 2024, according to a Form 4 filing with the SEC.
Summary
- On June 10, 2024, Neil Peterson, the Chief Operating Officer of Merit Medical Systems, exercised non-qualified stock options to acquire 7,500 shares of common stock at a price of $44.80 per share.
- Simultaneously, Peterson sold 7,500 shares of Merit Medical Systems common stock at a weighted average price of $81.846, with individual sales prices ranging from $81.325 to $82.185.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 11, 2024.
- Following these transactions, Peterson directly owns 14,819 shares of Merit Medical Systems common stock.
- Peterson also holds non-qualified stock options for an additional 58,576 shares at exercise prices of $54.40, $68.33 and $70.58.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction was pre-planned under a 10b5-1 trading plan. It doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
Insider transactions are common, and the use of 10b5-1 plans allows insiders to sell shares without being accused of trading on non-public information. The market will likely interpret this as a neutral event, given the pre-planned nature of the transaction.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine insider transaction under a pre-existing trading plan.
Key Dates
| Date | Description |
|---|---|
| 03/02/2019 | Non-qualified stock options become exercisable in equal annual installments of 20%. |
| 04/25/2020 | Non-qualified stock options become exercisable in equal annual installments of 20%. |
| 08/19/2022 | Non-qualified stock options become exercisable in equal annual installments of 25%. |
| 03/11/2024 | Reporting Person adopted a Rule 10b5-1 trading plan. |
| 02/28/2024 | Non-qualified stock options become exercisable in equal annual installments of 25%. |
| 06/10/2024 | Date of transaction: exercise of stock options and sale of shares. |
| 06/12/2024 | Date of Form 4 filing. |
| 03/02/2025 | Expiration date of non-qualified stock options. |
| 04/25/2026 | Expiration date of non-qualified stock options. |
| 08/19/2028 | Expiration date of non-qualified stock options. |
| 02/28/2030 | Expiration date of non-qualified stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.